Trial intelligence / Profile preview

Chengda rabies vaccine 2-1-1 post-exposure booster persistence study

CTR20140722Phase 4Active

Sponsor
Liaoning Chengda Biotechnology Co., Ltd.
Start
Jul 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of rabies vaccine (vero cell) in rabies, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started Jul 2015; status: active.

02

Drugs

rabies vaccine (vero cell)
03

Conditions

rabies

Beyond the preview

Go deeper on CTR20140722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call